The Endovascular Aneurysm Repair (EVAR) Market is estimated to be valued at USD 3.3 billion in 2025 and is projected to reach USD 5.3 billion by 2035, registering a compound annual growth rate (CAGR) of 4.8% over the forecast period.
Metric | Value |
---|---|
Endovascular Aneurysm Repair (EVAR) Market Estimated Value in (2025 E) | USD 3.3 billion |
Endovascular Aneurysm Repair (EVAR) Market Forecast Value in (2035 F) | USD 5.3 billion |
Forecast CAGR (2025 to 2035) | 4.8% |
The Endovascular Aneurysm Repair market is growing steadily, supported by increasing prevalence of abdominal aortic aneurysms and advancements in minimally invasive surgical procedures. Rising awareness among patients and physicians regarding the benefits of EVAR over traditional open surgeries, such as reduced hospital stays, lower procedural risks, and faster recovery times, is fueling adoption. The market is also benefiting from continuous technological improvements in stent graft design, imaging systems, and navigation tools that enhance surgical precision and long-term outcomes.
Growing geriatric populations worldwide, who are more prone to aneurysm formation, are driving demand further. Additionally, increasing healthcare expenditure, rising screening programs, and government initiatives focused on improving vascular disease management are expanding treatment accessibility.
The emergence of customized grafts and patient-specific EVAR solutions tailored to anatomical variations is adding momentum to market growth As the burden of cardiovascular diseases continues to rise globally, EVAR is expected to remain a preferred treatment option, positioning the market for sustained expansion in both developed and emerging economies.
The endovascular aneurysm repair (evar) market is segmented by techniques, demographics, and geographic regions. By techniques, endovascular aneurysm repair (evar) market is divided into Fenestrated EVAR, Adjunctive EVARs, Branched EVAR, Percutaneous EVAR, and Hybrid Procedures. In terms of demographics, endovascular aneurysm repair (evar) market is classified into Gender (Men And Women) and Age (Paediatric, Adult And Geriatric). Regionally, the endovascular aneurysm repair (evar) industry is classified into North America, Latin America, Western Europe, Eastern Europe, Balkan & Baltic Countries, Russia & Belarus, Central Asia, East Asia, South Asia & Pacific, and the Middle East & Africa.
The fenestrated EVAR techniques segment is projected to hold 32.2% of the market revenue share in 2025, making it one of the most significant contributors. This segment’s growth is being driven by its ability to treat complex aneurysms that involve branch arteries near the aortic arch, where conventional EVAR procedures are less effective. Fenestrated grafts allow for customization to patient-specific anatomies, thereby expanding treatment eligibility for high-risk patients who may otherwise have limited surgical options.
Their adaptability in maintaining blood flow to critical branch vessels while repairing aneurysms has enhanced clinical outcomes, supporting wider adoption. Continued innovations in fenestrated graft materials, deployment systems, and imaging-guided placement are further improving procedural safety and efficiency.
The segment is also gaining traction due to rising surgeon expertise, increasing acceptance in tertiary care hospitals, and growing demand for minimally invasive solutions With expanding clinical evidence supporting effectiveness, fenestrated EVAR techniques are expected to strengthen their market position over the coming years.
The gender demographics segment is anticipated to account for 52.7% of the market revenue share in 2025, making it the leading demographic category. This growth is primarily attributed to the higher prevalence of abdominal aortic aneurysms among men compared to women, which has established men as a dominant treatment group. However, increasing diagnosis among women due to advancements in imaging technologies and awareness campaigns is driving treatment uptake across both genders.
The growing aging population in both male and female categories is further supporting expansion, as aneurysm risk rises significantly with age. Healthcare systems are also emphasizing early detection programs for at-risk individuals, which is improving treatment outcomes and driving greater adoption across genders.
The availability of advanced EVAR solutions tailored for anatomical diversity in men and women is reinforcing market growth As gender-specific research continues to inform surgical practices and device development, the demographics segment is expected to maintain its leadership role, driven by rising prevalence, improved detection, and expanding treatment accessibility.
Abnormal enlargement of aorta in the abdomen of a person is a commonly occurring aneurysm in the world. Men and women of all ages are susceptible the incidence of an abdominal aortic aneurysm. Pain arising from such aneurysm can lead to paralysis or even cause death of the patient through cardiac disorders such as arterial stenosis.
Endovascular aneurysm repair (EVAR) is a collective term for all treatments that are directed to surgically cure the aortic aneurysm located in patient’s abdomen. The demand for EVAR devices continues to gain traction across medical organisations such as hospitals and specialty centres.
Country | CAGR |
---|---|
China | 6.5% |
India | 6.0% |
Germany | 5.5% |
France | 5.0% |
UK | 4.6% |
USA | 4.1% |
Brazil | 3.6% |
The Endovascular Aneurysm Repair (EVAR) Market is expected to register a CAGR of 4.8% during the forecast period, exhibiting varied country level momentum. China leads with the highest CAGR of 6.5%, followed by India at 6.0%. Developed markets such as Germany, France, and the UK continue to expand steadily, while the USA is likely to grow at consistent rates. Brazil posts the lowest CAGR at 3.6%, yet still underscores a broadly positive trajectory for the global Endovascular Aneurysm Repair (EVAR) Market. In 2024, Germany held a dominant revenue in the Western Europe market and is expected to grow with a CAGR of 5.5%. The USA Endovascular Aneurysm Repair (EVAR) Market is estimated to be valued at USD 1.1 billion in 2025 and is anticipated to reach a valuation of USD 1.7 billion by 2035. Sales are projected to rise at a CAGR of 4.1% over the forecast period between 2025 and 2035. While Japan and South Korea markets are estimated to be valued at USD 173.8 million and USD 98.5 million respectively in 2025.
Item | Value |
---|---|
Quantitative Units | USD 3.3 Billion |
Techniques | Fenestrated EVAR, Adjunctive EVARs, Branched EVAR, Percutaneous EVAR, and Hybrid Procedures |
Demographics | Gender (Men And Women) and Age (Paediatric, Adult And Geriatric) |
Regions Covered | North America, Europe, Asia-Pacific, Latin America, Middle East & Africa |
Country Covered | United States, Canada, Germany, France, United Kingdom, China, Japan, India, Brazil, South Africa |
Key Companies Profiled | Cardinal Health Inc, Lombard Medical Inc, W. L. Gore & Associates Inc, Medtronic Plc, Koninklijke Philips N.V., Endologix Inc, Abbott Laboratories, Cook Medical, Becton, Dickinson and Company, and Terumo Medical Corporation |
The global endovascular aneurysm repair (evar) market is estimated to be valued at USD 3.3 billion in 2025.
The market size for the endovascular aneurysm repair (evar) market is projected to reach USD 5.3 billion by 2035.
The endovascular aneurysm repair (evar) market is expected to grow at a 4.8% CAGR between 2025 and 2035.
The key product types in endovascular aneurysm repair (evar) market are fenestrated evar, adjunctive evars, branched evar, percutaneous evar and hybrid procedures.
In terms of demographics, gender (men and women) segment to command 52.7% share in the endovascular aneurysm repair (evar) market in 2025.
Explore Similar Insights
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Chat With
MaRIA